Biexponential display
placeholder
Compensation tip
placeholder
FMO controls
placeholder
Annotate your experiment to score points
placeholder
Viability marker
placeholder
1 potato, 2 potato
placeholder
Why wash?
...
Ranking of fluorochromes - not instrument specific (specific soon to be uploaded on instrument configurations)
| Very Bright | Bright | Okay | Dim |
|---|---|---|---|
| PE | APCR700 | BV510 | APCCY7 |
| PECF594 | BUV661 | BUV395 | DYLIGHT800 |
| PEDAZZLE594 | BV605 | FITC | APCH7 |
| PECY7 | BUV737 | PERCPCY55 | AF700 |
| PECY55 | APC | BUV496 | PERCP |
| BB515 | AF647 | AF488 | APCFIRE |
| BV421 | BV786 | BV570 | V500 |
| BV650 | APCR700 | PB | |
| BV711 | BV750 | V450 | |
| BB700 | BV480 | BUV805 | |
| BYG584 | BUV615 | ||
| BB790 | BUV563 | ||
| PECY5 | |||
BB630 | |||
| BB660 | |||
Clone selection...
Ensure antibody clone / manufacturer differences are tested when selecting antibodies for a panel.
a)
b)
(a) Two clones were available for the transcription factor PU.1 (found in some myeloid cell subsets). Both are on the same fluorophore, but only clone 7C6B05 was able to resolve a separate population. A titration was preformed, but the population was never discernible by clone 7C2C34.
(b) Here the same clone from two different companies on two similar fluorophores was evaluated on the same PBMC donor. You can see company A conjugated-antibody was able to resolve a CD3+ CRTH2+ population, however company B’s conjugated antibody was not. Increasing the concentration did not help and simply resulted in more spread in the negative.
Viability titration
Benefits of titrating not only antibodies but viability dyes.
(above) Titration revealing populations that are unresolvable with an abundance of antibody due to non-specific binding.
(below) Often overlooked, titrating the amine-reactive viability markers can result in tighter negative populations due to minimised unbound fluorophores and baseline restoration, which has less of an effect on other important markers even in the negative (live) population.
Annotate your experiment before or during data acquisition
The MIFlowCyt Standard (minimum information necessary for flow cytometry experiments) outlines the minumum information required to report the experimental details of flow cytometry experiments.
Allocate time to annotate appropriate metadata, labelling the fluorochromes & antibodies used, as well as other experimental information to allow re-interpretation of the results in the future.
Identify dead cells and debris
Dead cells can lead to inaccurate frequencies and can increase non-specific staining. Identifying them with one or more of the many viability/apoptotic markers can clean up your resultant data significantly making interpretation significantly easier. DAPI, 7-AAD, PI, TO-PRO-3, SYTOX green, DRAQ7, Calcein-AM and amine reactive dyes are examples that can be used.
Centrifuging fluorescent antibodies prior to using them may remove aggregates resulting in cleaner data
Sometimes you may notice a number of events above the obvious positive population, shown below. On occasion these may be fluorescent molecule aggregations that are super bright. 1 trick (and I hope to upload a before and after example when I dig it up) is to either individually centrifuge antibodies before using them, or centrifuging the cocktail before adding to cells in order to remove fluorescent aggregates. In a micro-centrifuge, 10000-12000g, chilled, 5 minutes can be used to pellet aggregates, followed by pipetting the supernatant.
...
The digital instruments at WRHFlow allow the collection of additional parameters that can be used to distinguish cell doublets and aggregates of cells from single cells before enumeration.
Avoid clumps in your sample - filter them through a mesh filter
...
Good practice includes having a time vs. fluorescent parameter (off the last laser used) to monitor your acquisition to spot problems and fix them before finishing running your sample.
